(1)
Abola, P.; Jabishvili, G. Incidence of Adverse and Safety Events in Individuals With Parkinson’s Disease Treated With Catechol-O-Methyltransferase Inhibitor Opicapone As an Add-on to Levodopa Treatment: A Systematic Review and Meta-Analysis. Prospect. Pharm. Sci. 2025, 23, 175-185.